The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Open accessAbstract
OBJECTIVE: Despite the negative effects of depression in Parkinson's disease, there is currently no evidence-based standard of care. The purpose of this study was to examine the efficacy of individually administered cognitive-behavioral therapy (CBT), relative to clinical monitoring (with no new treatment), for depression in this medical population. METHOD: Eighty depressed (based on DSM-IV criteria) patients with Parkinson's disease participated in a randomized, controlled trial of CBT relative to clinical monitoring (1:1 ratio) in an academic medical center from April 2007 to July 2010. All patients continued to maintain stable medication regimens under the care of their personal physicians. The 17-item Hamilton Depression Rating Scale (HAM-D) total score was the primary outcome. CBT was modified to meet the unique needs of the Parkinson's disease population and provided for 10 weeks. Assessments were completed by blind raters at baseline and 5 (midpoint), 10 (end of treatment), and 14 weeks (follow-up evaluation) postrandomization. RESULTS: The CBT group reported greater reductions in depression (change in HAM-D score) than the clinical monitoring group. At week 10, the mean HAM-D score change was 7.35 for CBT relative to 0.05 for clinical monitoring. CBT was also superior to clinical monitoring on several secondary outcomes (i.e., Beck Depression Inventory scores, anxiety, quality of life, coping, Parkinson's disease symptom ratings). There were more treatment responders in the CBT group than the clinical monitoring group (56% versus 8%, respectively). CONCLUSIONS: CBT may be a viable approach for the treatment of depression in Parkinson's disease. Further research is needed to replicate and extend these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To date, there is very little research into the effectiveness of psychological interventions in PD, with only a small number of studies [10–12] investigating the feasibility and effectiveness of cognitive behavioural therapy (CBT) in the treatment of depression and anxiety.”
From Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: The study protocol of a randomised pilot trial (2017) · cites this paper as [10]
In the citing paper
“CBT has also been found to reduce symptoms of depressive disorders in adults with chronic somatic conditions [18–20]”
From Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial (2020) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Cognitive Therapy for Depression
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,678
(1976) · Medical Entomology and Zoology · Cited by 8,899
You want to measure coping but your protocol’ too long: Consider the brief cope
Carver, C. S. (1997) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0401_6 · Cited by 7,361
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Research works printed but not linked: 4
- Farabaugh A, 2010, Psychosomatics, 51, 124
- Young J, 1980, Cognitive Therapy Scale Rating Manual
- Marsh L, 2007, Mov Disord, 22, XIV
- 10.1097/00019442-200510000-00003 · DOI
Cited by
Sorted by citations
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
Seppi, K., Chaudhuri, К. R., Coelho, M. M., Fox, S. H., Katzenschlager, R., Perez‐Lloret, S., Weintraub, D. A., & Sampaio, C. (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,013
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
“In addition, cognitive behavior therapy has been shown to be efficacious,(5) but its role in the management of cognitive impairment in PD is not yet cleart.(56) Among the disorders of affect, both anxiety and apathy in PD have received less attention than depression despite their frequent occurrence (30%-40% for each…”
Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00462-6 · Cited by 632
Depression and Parkinson’s Disease: Current Knowledge
Marsh, L. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0409-5 · Cited by 434
Johnsen, T. J., & Friborg, O. (2015) · Psychological Bulletin · doi:10.1037/bul0000015 · Cited by 331
Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature
Mosley, P. E., Moodie, R., & Dissanayaka, N. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988717720302 · Cited by 292
How much psychotherapy is needed to treat depression? A metaregression analysis
Cuijpers, P., Huibers, M., Daniel Ebert, D., Koole, S. L., & Andersson, G. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.030 · Cited by 258
Effect of treatments for depression on quality of life: a meta-analysis
Hofmann, S. G., Curtiss, J., Carpenter, J. K., & Kind, S. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1304445 · Cited by 189
Prange, S., Klinger, H., Laurencin, C., Danaila, T., & Thobois, S. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00942-1 · Cited by 193
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 172
Anxiety in Parkinson's disease: identification and management
Chen, J. J., & Marsh, L. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613495723 · Cited by 161
Effect of psychotherapy for depression on quality of life: meta-analysis
Kolovos, S., Kleiboer, A., & Cuijpers, P. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.175059 · Cited by 153
Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis
Bomasang-Layno, E., Fadlon, I., Murray, A. N., & Himelhoch, S. S. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.018 · Cited by 142
Cristea, I. A., Huibers, M. J. H., David, D., Hollon, S. D., Andersson, G., & Cuijpers, P. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.08.003 · Cited by 135
Ahmad, M. H., Rizvi, M. M. A., Ali, M., & Mondal, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101840 · Cited by 141
Troeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132
Dobkin, R. D., Mann, S. L., Gara, M. A., Interian, A., Rodriguez, K. M., & Menza, M. (2020) · Neurology · doi:10.1212/wnl.0000000000009292 · Cited by 127
Self-citationDisease progression in patients with single, large-scale mitochondrial DNA deletions
Grady, J. P., Campbell, G. R., Ratnaike, T. E., Blakely, E. L., Falkous, G., Nesbitt, V., Schaefer, A. M., McNally, R., Gorman, G. S., Taylor, R. W., et al. (2013) · Brain · doi:10.1093/brain/awt321 · Cited by 118
Psychiatric aspects of Parkinson’s disease
Grover, S., Somaiya, M. P., Kumar, S., & Avasthi, A. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143197 · Cited by 116
Neuropsychiatric Symptoms in Parkinson’s Disease
Aarsland, D., & Kramberger, M. G. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150604 · Cited by 105
Management of Depression in Parkinson's Disease: A Systematic Review
STARKSTEIN, S. E., & Brockman, S. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12507 · Cited by 108
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
Samuel, M., Rodríguez‐Oroz, M., Antonini, A., Brotchie, J. M., Chaudhuri, К. R., Brown, R. G., Galpern, W. R., Nirenberg, M. J., Okun, M. S., & Lang, A. E. (2015) · Movement Disorders · doi:10.1002/mds.26099 · Cited by 102
Quality of Life and Nonmotor Symptoms in Parkinson's Disease
Barone, P., Erro, R., & Picillo, M. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.023 · Cited by 98
New clinical trials for nonmotor manifestations of Parkinson's disease
Schrag, A. E., Sauerbier, A., & Chaudhuri, К. R. (2015) · Movement Disorders · doi:10.1002/mds.26415 · Cited by 96
Thom, R. P., Silbersweig, D., & BOLAND, R. J. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000678 · Cited by 98
Comorbidities in Neurology: Is adenosine the common link?
Boison, D., & Aronica, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.031 · Cited by 97
Drug treatment strategies for depression in Parkinson disease
Ryan, M. A., Eatmon, C. V., & Slevin, J. T. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1612877 · Cited by 94
Barriers to mental health care utilization in Parkinson's disease
Dobkin, R. D., Rubino, J. T., Friedman, J., Allen, L. A., Gara, M. A., & Menza, M. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713481269 · Cited by 93
Self-citationCognitive Behavioral Therapy in Movement Disorders: A Review
Berardelli, I., Pasquini, M., Roselli, V., Biondi, M., Berardelli, A., & Fabbrini, G. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12160 · Cited by 91
Management of psychiatric and cognitive complications in Parkinson’s disease
Weintraub, D. A., Aarsland, D., Biundo, R., Dobkin, R. D., Goldman, J. G., & Lewis, S. J. G. (2022) · BMJ · doi:10.1136/bmj-2021-068718 · Cited by 91
Self-citationTelephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Dobkin, R. D., Menza, M., Allen, L. A., Tiu, J., Friedman, J., Bienfait, K. L., Gara, M. A., & Mark, M. H. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422529 · Cited by 88
Self-citationRemote delivery of psychological interventions for Parkinson's disease.
Swalwell, C., Pachana, N. A., & Dissanayaka, N. N. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218000340 · Cited by 87
What a neurologist should know about depression in Parkinson’s disease
Timmer, M. H. M., Beek, M. H. C. T. V., Bloem, B. R., & Esselink, R. A. J. (2017) · Practical Neurology · doi:10.1136/practneurol-2017-001650 · Cited by 87
Goldman, J. G., Volpe, D., Ellis, T. D., Hirsch, M. A., Johnson, J. A., Wood, J., Vinagre‐Aragón, A., Biundo, R., Rocco, A. D., Kasman, G. S., et al. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230117 · Cited by 93
Troeung, L., Egan, S. J., & Gasson, N. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-19 · Cited by 85
Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review
Koychev, I. G., & Okai, D. (2017) · Evidence-Based Mental Health · doi:10.1136/eb-2016-102574 · Cited by 88
The effect of psychotherapy for depression on improvements in social functioning: a meta-analysis
Renner, F., Cuijpers, P., & Huibers, M. J. H. (2014) · Psychological Medicine · doi:10.1017/s0033291713003152 · Cited by 82
Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease
Pachana, N. A., Egan, S. J., Laidlaw, K., Dissanayaka, N., Byrne, G. J., Brockman, S., Marsh, R., & Starkstein, S. (2013) · Movement Disorders · doi:10.1002/mds.25689 · Cited by 82
Antidepressants for depression in Parkinson’s disease: systematic review and meta-analysis
Rocha, F. L., Murad, M. G., Stumpf, B. P., Hara, C., & Fuzikawa, C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113478282 · Cited by 82
Drug Choices and Advancements for Managing Depression in Parkinson's Disease
Assogna, F., Pellicano, C., Savini, C., Macchiusi, L., Pellicano, G. R., Alborghetti, M., Caltagirone, C., Spalletta, G., & Pontieri, F. E. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191016094857 · Cited by 83
Hurt, C. S., Burn, D. J., Hindle, J., Samuel, M., Wilson, K., & Brown, R. G. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12043 · Cited by 80
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
Connolly, B. S., & Fox, S. H. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0238-x · Cited by 78
Landau, S., Harris, V., Burn, D. J., Hindle, J. V., Hurt, C. S., Samuel, M., Wilson, K. C., & Brown, R. G. (2015) · Psychological Medicine · doi:10.1017/s0033291715002196 · Cited by 78
The effects of psychotherapy for depression on anxiety symptoms: a meta-analysis
Weitz, E., Kleiboer, A., van Straten, A., & Cuijpers, P. (2018) · Psychological Medicine · doi:10.1017/s0033291717003622 · Cited by 77
Lewis, C. J., Maier, F., Horstkötter, N., Zywczok, A., Witt, K., Eggers, C., Meyer, T. D., Dembek, T. A., Maarouf, M. M., Moro, E., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714001081 · Cited by 75
Psychosocial Interventions for Depression and Anxiety in Parkinson's Disease
Nagle-Yang, S. M., Sajatovic, M., & Walter, B. L. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712445096 · Cited by 80
Borisovskaya, A., Bryson, W. C., Buchholz, J. R., Samii, A., & Soo Borson, B. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2016-0002 · Cited by 75
Zarotti, N., Eccles, F. J. R., Foley, J. A., Paget, A., Gunn, S., Leroi, I., & Simpson, J. (2021) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12321 · Cited by 73
Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
Moonen, A. J. H., Mulders, A. E. P., Defebvre, L., Duits, A., Flinois, B., Köhler, S., Kuijf, M. L., Leterme, A., Servant, D., de Vugt, M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28533 · Cited by 71
Calleo, J. S., Amspoker, A. B., Sarwar, A. I., Kunik, M. E., Jankovic, J., Marsh, L., York, M., & Stanley, M. A. (2015) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988715588831 · Cited by 71
Mood disorders in Parkinson's disease
Tan, L. C. S. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70024-4 · Cited by 70
Impact of Tremor on Patients With Early Stage Parkinson's Disease
Heusinkveld, L. E., Hacker, M. L., Turchan, M., Davis, T. L., & Charles, D. P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00628 · Cited by 69
Initial management of Parkinson's disease
Goetz, C. G., & Pal, G. D. (2014) · BMJ · doi:10.1136/bmj.g6258 · Cited by 72
Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
Mueller, C., Rajkumar, A. P., Wan, Y.-M., Velayudhan, L., Ffytche, D. H., Chaudhuri, К. R., & Aarsland, D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0540-6 · Cited by 78
A Survey of Parkinson's Disease Patients: Most Bothersome Symptoms and Coping Preferences
Uebelacker, L. A., Epstein-Lubow, G. P., Lewis, T., Broughton, M. K., & Friedman, J. H. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-140446 · Cited by 67
Self-citationPsychiatric syndromes in Parkinson's disease
STARKSTEIN, S. E., Brockman, S., & Hayhow, B. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283577ed1 · Cited by 66
Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
Egan, S. J., Laidlaw, K., & STARKSTEIN, S. E. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150542 · Cited by 66
Pontone, G. M., Dissanayaka, N. N., Apostolova, L. G., Brown, R. G., Dobkin, R. D., Dujardin, K., Friedman, J. H., Leentjens, A. F. G., Lenze, E. J., Marsh, L., et al. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0102-8 · Cited by 71
Self-citationDobkin, R. D., Rubino, J. T., Allen, L. A., Friedman, J., Gara, M. A., Mark, M. H., & Menza, M. A. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0027695 · Cited by 62
Self-citationFrom Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Toader, C., Dobrin, N., Brehar, F.-M., Popa, C., Covache-Busuioc, R.-A., Glavan, L.-A., Costin, H. P., Bratu, B.-G., Corlatescu, A.-D., Popa, A. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216119 · Cited by 63
Sajatovic, M., Ridgel, A. L., Walter, E. M., Tatsuoka, C. M., Colón-Zimmermann, K., Ramsey, R. K., Welter, E., Gunzler, S. A., Whitney, C. M., & Walter, B. L. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s135551 · Cited by 59
Cognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease
Reynolds, G. O., Saint-Hilaire, M., Thomas, C. A., Barlow, D. H., & Cronin-Golomb, A. (2020) · Behavior Modification · doi:10.1177/0145445519838828 · Cited by 59
A Stage-Based Approach to Therapy in Parkinson’s Disease
Carrarini, C., Russo, M., Dono, F., Pietro, M. D., Rispoli, M. G., Stefano, V. D., Ferri, L., Barbone, F., Vitale, M., Thomas, A., et al. (2019) · Biomolecules · doi:10.3390/biom9080388 · Cited by 58
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 59
Cognitive Behavior Therapy for Anxiety in Parkinson’s Disease: Outcomes for Patients and Caregivers
Dissanayaka, N. N., Pye, D., Mitchell, L. K., Byrne, G. J., O’Sullivan, J. D., Marsh, R., & Pachana, N. A. (2016) · Clinical Gerontologist · doi:10.1080/07317115.2016.1240131 · Cited by 58
Psychiatric issues in cognitive impairment
Aarsland, D., Taylor, J., & Weintraub, D. A. (2014) · Movement Disorders · doi:10.1002/mds.25873 · Cited by 56
Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review
Goodarzi, Z., Mele, B., Guo, S., Hanson, H. M., Jetté, N., Patten, S. B., Pringsheim, T. M., & Holroyd-Leduc, J. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0754-5 · Cited by 57
Parkinson and depression: review and outlook
Laux, G. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02456-3 · Cited by 52
A Framework to Support Cognitive Behavior Therapy for Emotional Disorder After Stroke
Kneebone, I. (2015) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2015.02.001 · Cited by 52
Simpson, J., Lekwuwa, G., & Crawford, T. J. (2014) · Disability and Rehabilitation · doi:10.3109/09638288.2014.883442 · Cited by 57
Cognition, coping, and outcome in Parkinson's disease
Hurt, C. S., Landau, S., Burn, D. J., Hindle, J. V., Samuel, M., Wilson, K., & Brown, R. G. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000749 · Cited by 52
Fernie, B. A., Kollmann, J., & Brown, R. G. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.012 · Cited by 51
Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment
Dobkin, R. D., Mann, S., Weintraub, D. A., Rodriguez, K. M., Miller, R. B., Hill, L. S., King, A. R., Gara, M. A., & Interian, A. (2021) · Movement Disorders · doi:10.1002/mds.28548 · Cited by 51
Self-citationCristea, I. A., Ștefan, S., Karyotaki, E., David, D., Hollon, S. D., & Cuijpers, P. J. (2017) · Psychological Bulletin · doi:10.1037/bul0000062 · Cited by 55
Psychological Predictors of Anxiety and Depression in Parkinson's Disease: A Systematic Review
Garlovsky, J. K., Overton, P. G., & Simpson, J. (2016) · Journal of Clinical Psychology · doi:10.1002/jclp.22308 · Cited by 49
Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review
Armento, M. E. A., Stanley, M. A., Marsh, L., Kunik, M. E., York, M. K., Bush, A. L., & Calleo, J. S. (2012) · Journal of Parkinson's Disease · doi:10.3233/jpd-2012-12080 · Cited by 49
Anxiety and Depression in Parkinson’s Disease
Djamshidian, A., & Friedman, J. H. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0285-6 · Cited by 47
Self-citationLuo, F., Ye, M., Lv, T., Hu, B., Chen, J., Yan, J., Wang, A., Chen, F., He, Z., Ding, Z., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.793804 · Cited by 50
Mood Disorders and Anxiety in Parkinson’s Disease: Current Concepts
Lintel, H. A., Corpuz, T. V., Paracha, S.-U.-R., & Grossberg, G. T. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211018267 · Cited by 51
Scott, A. J., Bisby, M. A., Heriseanu, A. I., Salameh, Y., Karin, E., Fogliati, R., Dudeney, J., Gandy, M., McLellan, L. F., Wootton, B., et al. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102353 · Cited by 45
The effects of psychotherapy for adult depression on social support: a meta-analysis
Park, M., Cuijpers, P., van Straten, A., & Reynolds, C. F. (2014) · Cognitive Therapy and Research · doi:10.1007/s10608-014-9630-z · Cited by 44
Staying hidden: The burden of stigma in PD
McDaniels, B., Pontone, G. M., Mathur, S., & Subramanian, I. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105838 · Cited by 44
Rodgers, S. H., Schütze, R., Gasson, N., Anderson, R. A., Kane, R. T., Starkstein, S., Morgan-Lowes, K., & Egan, S. J. (2019) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246581800070x · Cited by 43
Pagonabarraga, J., Álamo, C., Castellanos, M., Díaz, S., & Manzano, S. (2023) · Brain Sciences · doi:10.3390/brainsci13020318 · Cited by 49
Depression in Parkinson's Disease: Identification and Management
Chen, J. J., & Marsh, L. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1314 · Cited by 43
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs
Rukavina, K., Batzu, L., Boogers, A., Abundes‐Corona, A., Bruno, V. A., & Chaudhuri, К. R. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1883428 · Cited by 44
Ren, W., Qiu, H., Yang, Y., Zhu, X., Zhu, C., Mao, G., Mao, S., Lin, Y., Shen, S., Li, C., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.026 · Cited by 41
Metacognitions, anxiety, and distress related to motor fluctuations in Parkinson's disease.
Brown, R. G., & Fernie, B. A. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.09.021 · Cited by 43
Kraepelien, M., Schibbye, R., Månsson, K., Sundström, C., Riggare, S., Andersson, G., Lindefors, N., Svenningsson, P., & Kaldo, V. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-191894 · Cited by 41
Hummel, J., Weisbrod, C., Boesch, L., Himpler, K., Hauer, K. A., Hautzinger, M., Gäbel, A., Zieschang, T., Fickelscherer, A., Diener, S. J., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.10.009 · Cited by 44
Management of psychiatric disorders in Parkinson's disease
Weintraub, D. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00875-w · Cited by 42
Hong, C., Tan, S., & Huang, T. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.03.031 · Cited by 42
Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial
Dobkin, R. D., Interian, A., Durland, J. L., Gara, M. A., & Menza, M. A. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718783274 · Cited by 39
Self-citationCharacteristics and Treatment of Anxiety Disorders in Parkinson's Disease
Dissanayaka, N. N., White, E., O’Sullivan, J. D., Marsh, R., Silburn, P. A., Copland, D. A., Mellick, G. D., & Byrne, G. J. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12157 · Cited by 39
Depression in Parkinson's Disease: A Narrative Review
Chikatimalla, R., Dasaradhan, T., Koneti, J., Cherukuri, S. P., Kalluru, R., & Gadde, S. (2022) · Cureus · doi:10.7759/cureus.27750 · Cited by 45
Six, S. G., Byrne, K., Aly, H., & Harris, M. W. (2022) · JMIR Mental Health · doi:10.2196/39516 · Cited by 31
Parkinson’s Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022)
Zhang, T., Yang, R., Pan, J., & Huang, S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s403002 · Cited by 38
Butterfield, L. C., Cimino, C. R., Salazar, R., Sanchez-Ramos, J., Bowers, D., & Okun, M. S. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716673467 · Cited by 38
Clare, L., Teale, J. C., Toms, G., Kudlicka, A., Evans, I., Abrahams, S., Goldstein, L. H., Hindle, J. V., Ho, A. K., Jahanshahi, M., et al. (2019) · NeuroRehabilitation · doi:10.3233/nre-172353 · Cited by 37
Laidlaw, K., & Kishita, N. (2015) · GeroPsych · doi:10.1024/1662-9647/a000128 · Cited by 37
Metadata
- Authors
- Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J.
- Affiliations
- University of Medicine and Dentistry of New Jersey (US)
- ORCID
- Dobkin, Roseanne D.
- Venue
- American Journal of Psychiatry
- Published
- 2011-10
- Volume
- 168
- Issue
- 10
- Pages
- 1066-1074
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3186855
- OpenAlex
- W1969355958
- Cited by
- 310
- References
- 49
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 18 · 2023: 17 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 21 · 2018: 15 · 2017: 24 · 2016: 23 · 2015: 29 · 2014: 24 · 2013: 30 · 2012: 12
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (K23NS052155)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cognitive behavioral therapy, depression, Parkinson's disease, treatment efficacy, patient monitoring, Hamilton Depression Rating Scale, anxiety, quality of life, coping
- MeSH terms
- Adult, Aged, Aged, 80 and over, Depressive Disorder, Female, Humans, Male, Middle Aged, Parkinson Disease, Cognitive Behavioral Therapy, Single-Blind Method, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
